{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:52:29Z","timestamp":1770979949355,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"MEXT KAKENHI (Grant-in-Aid for Exploratory Research)","award":["16659066"],"award-info":[{"award-number":["16659066"]}]},{"name":"MEXT KAKENHI (Grant-in-Aid for Young Scientists (B))","award":["17790101"],"award-info":[{"award-number":["17790101"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.pbb.2016.02.006","type":"journal-article","created":{"date-parts":[[2016,2,16]],"date-time":"2016-02-16T00:02:21Z","timestamp":1455580941000},"page":"26-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Centrally acting non-narcotic antitussives prevent hyperactivity in mice: Involvement of GIRK channels"],"prefix":"10.1016","volume":"144","author":[{"given":"Fumio","family":"Soeda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Fujieda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizue","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Shirasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Takahama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2016.02.006_bb0005","first-page":"219P","article-title":"Centrally acting antitussives inhibit GIRK currents mediated by various receptors","volume":"91","author":"Abe","year":"2003","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.pbb.2016.02.006_bb0010","series-title":"Diagnostic and Statistical Manual Of Mental Disorders: DSM-V","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.pbb.2016.02.006_bb0015","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/sj.mp.4001474","article-title":"The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit\/hyperactivity disorder","volume":"9","author":"Avale","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pbb.2016.02.006_bb0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nn1181","article-title":"Bi-directional effects of GABAB receptor agonists on the mesolimbic dopamine system","volume":"7","author":"Cruz","year":"2004","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pbb.2016.02.006_bb0025","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s12272-013-0037-2","article-title":"Abuse and dependence liability analysis of methylphenidate in the spontaneously hypertensive rat model of attention-deficit\/hyperactivity disorder (ADHD): what have we learned?","volume":"36","author":"Dela Pena","year":"2013","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.pbb.2016.02.006_bb0030","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.psychres.2013.11.008","article-title":"Abuse of methylphenidate in Germany: Data from spontaneous reports of adverse drug reactions","volume":"215","author":"Gahr","year":"2014","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pbb.2016.02.006_bb0035","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0024-3205(96)00052-5","article-title":"Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters","volume":"58","author":"Gatley","year":"1996","journal-title":"Life Sci."},{"key":"10.1016\/j.pbb.2016.02.006_bb0040","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bbr.2015.02.012","article-title":"Tipepidine increases dopamine level in the nucleus accumbens without methamphetamine-like behavioral sensitization","volume":"284","author":"Hamao","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2016.02.006_bb0045","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuroscience.2013.07.044","article-title":"Tipepidine activates VTA dopamine neuron via inhibiting dopamine D(2) receptor-mediated inward rectifying K(+) current","volume":"252","author":"Hamasaki","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2016.02.006_bb0050","unstructured":"Hayasaki K, Hamao K, Kawaura K, Soeda F, Shirasaki T, Takahama K. Neurochemical studies on the mechanism of a novel antidepressant like action of tipepidine. The 133rd Annual Meeting of the Pharmaceutical Society of Japan Abstract. 2013:GS-1-5."},{"key":"10.1016\/j.pbb.2016.02.006_bb0055","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0165-3806(83)90105-0","article-title":"Locomotor hyperactivity in neonatal rats following electrolytic lesions of mesocortical dopamine neurons","volume":"285","author":"Heffner","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2016.02.006_bb0060","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bbr.2010.08.010","article-title":"The potent inhibitory effect of tipepidine on marble-burying behavior in mice","volume":"216","author":"Honda","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2016.02.006_bb0065","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/S0028-3908(00)00092-7","article-title":"Inhibition of the 5-HT(1A) receptor-mediated inwardly rectifying K(+) current by dextromethorphan in rat dorsal raphe neurones","volume":"39","author":"Ishibashi","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2016.02.006_bb0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.brainres.2013.03.034","article-title":"Effect of tipepidine with novel antidepressant-like action on c-fos-like protein expression in rat brain","volume":"1513","author":"Kawahara","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2016.02.006_bb0075","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.neulet.2010.07.003","article-title":"Antidepressant-like effect of centrally acting non-narcotic antitussive caramiphen in a forced swimming test","volume":"481","author":"Kawaura","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pbb.2016.02.006_bb0080","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.bbr.2009.07.004","article-title":"The centrally acting non-narcotic antitussive tipepidine produces antidepressant-like effect in the forced swimming test in rats","volume":"205","author":"Kawaura","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2016.02.006_bb0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40263-012-0019-9","article-title":"Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder","volume":"27","author":"Martinez-Raga","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pbb.2016.02.006_bb0090","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.euroneuro.2012.06.011","article-title":"Meta-analysis of increased heart rate and blood pressure associated with CNS stimulant treatment of ADHD in adults","volume":"23","author":"Mick","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2016.02.006_bb0095","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1126\/science.2820058","article-title":"Cocaine receptors on dopamine transporters are related to self-administration of cocaine","volume":"237","author":"Ritz","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.pbb.2016.02.006_bb0100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/NDT.S58480","article-title":"Tipepidine in children with attention deficit\/hyperactivity disorder: a 4-week, open-label, preliminary study","volume":"10","author":"Sasaki","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.pbb.2016.02.006_bb0105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00426384","article-title":"Dopaminergic but not noradrenergic mediation of hyperactivity and performance deficits in the developing rat pup","volume":"82","author":"Shaywitz","year":"1984","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2016.02.006_bb0110","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1126\/science.942800","article-title":"Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction","volume":"191","author":"Shaywitz","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.pbb.2016.02.006_bb0115","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/tox.21749","article-title":"Cloperastine rescues impairment of passive avoidance response in mice prenatally exposed to diethylstilbestrol","volume":"29","author":"Soeda","year":"2014","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.pbb.2016.02.006_bb0120","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1248\/jhs.51.488","article-title":"Prenatal exposure to a low dose of 4-hydroxy-2\u2032, 3, 3\u2032, 4\u2032, 5\u2032-pentachlorobiphenyl increases emotional behaviors in mice","volume":"51","author":"Soeda","year":"2005","journal-title":"J. Health Sci."},{"key":"10.1016\/j.pbb.2016.02.006_bb0125","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(97)11450-7","article-title":"Attention-deficit hyperactivity disorder and hyperkinetic disorder","volume":"351","author":"Swanson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.pbb.2016.02.006_bb0130","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-540-79842-2_11","article-title":"Central mechanisms III: neuronal mechanisms of action of centrally acting antitussives using electrophysiological and neurochemical study approaches","volume":"219-40","author":"Takahama","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.pbb.2016.02.006_bb0135","doi-asserted-by":"crossref","first-page":"RC121","DOI":"10.1523\/JNEUROSCI.21-02-j0001.2001","article-title":"Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain","volume":"21","author":"Volkow","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2016.02.006_bb0140","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1139\/Y09-078","article-title":"Ameliorating effects of cloperastine on dysfunction of the urinary bladder caused by cerebral infarction in conscious rats","volume":"87","author":"Yamamoto","year":"2009","journal-title":"Can. J. Physiol. Pharmacol."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009130571630017X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009130571630017X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T12:46:28Z","timestamp":1567601188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009130571630017X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":28,"alternative-id":["S009130571630017X"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2016.02.006","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Centrally acting non-narcotic antitussives prevent hyperactivity in mice: Involvement of GIRK channels","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2016.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}